Stock Market News8 months Can biotech startups upstage Eli Lilly and Novo Nordisk? The Economist
Smaller drugmakers are enjoying a revival
X1 day Eli Lilly (LLY) Stock Sinks As Market Gains: What You Should Know Zacks
X1 day 4 Drug, Biotech Stocks Rising More Than 50% in 2024 With Room to Grow Zacks
X2 days Should You Invest in the VanEck Biotech ETF (BBH)? Zacks
X2 days Here’s Why Amgen (AMGN) Gained But Lagged the Market Today Zacks
X2 days Eli Lilly, Novo Nordisk Stocks Rise. Only One Is Operating From a Position of Strength. Yahoo Finance
X2 days 5 Biotech Breakthrough Stocks to Watch in 2025 Zacks
X2 days Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It Zacks
X2 days Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know Zacks
X3 days Lilly’s Zepbound Receives FDA Approval for Sleep Apnea Zacks
X3 days Investors optimistic about continued biotech and medtech IPO resurgence in 2025 Yahoo Finance
X3 days Eli Lilly, Novo Nordisk Stocks Rise. One of These Obesity Drugmakers Just Hit a Landmark. Yahoo Finance
X3 days Stocks to Watch Monday: Honda, Novo Nordisk, Eli Lilly, Xerox Yahoo Finance
X3 days This Beaten-Down Biotech Stock Just Got Some Good News: Time to Buy? Yahoo Finance
X5 days Is Now a Good Time to Buy the Dip in Eli Lilly Stock? Yahoo Finance
X5 days Eli Lilly’s Obesity Drug Wins Approval In Sleep Apnea; Will ResMed Dive? Investor's Business Daily
X5 days Stocks to Watch Friday: Trump Media, Novo Nordisk, Eli Lilly, Tesla Yahoo Finance
X5 days Stocks on the Move: Uber, Carmax, Novo Nordisk, Eli Lilly, Merck, Crown Castle and Accenture YouTube
X5 days Nvidia, Eli Lilly lead Friday’s market cap stock movers Investing.com
X5 days There’s a New Obesity King The Wall Street Journal
X5 days Gilead Stock Gains 15.4% in a Year: Should You Buy, Sell or Hold? Zacks
X5 days Eli Lilly: Improved Competitive Position In Obesity Market, But Strong Execution Is A Must Now Seeking Alpha
X5 days LLY Stock Up as FDA Removes Mounjaro, Zepbound From Shortage List Zacks
X6 days FedEx, Eli Lilly, Occidental rise premarket; Nike, Novo Nordisk fall Investing.com
X6 days Novo Nordisk’s new weight-loss drug works better, but not as well as expected MarketWatch
X6 days Eli Lilly dips despite FDA confirming shortage of GLP-1 tirzepatide is over Investing.com
X6 days 4 Biotech Stocks Most Wall Street Analysts Are Bullish About Zacks
X6 days KRYS Reports Upbeat Initial Data From Lung Cancer Study of KB707 Zacks
X6 days IBD 50’s Hims & Hers Tumbles After FDA Pulls Lilly’s Weight-Loss Drug From Shortage List Investor's Business Daily
X6 days FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage CNBC
X7 days Merck Enters Obesity Space, Buys Rights to Hansoh’s Oral GLP-1 Drug Zacks
X7 days Zealand Pharma And Eli Lilly: Strategic Focus On Weight Management And Future Outlook Seeking Alpha
X1 week Top-Notch Biotech Mesoblast Skyrockets On Immune Condition Approval Investor's Business Daily
X1 week Biotech Stock Roundup: Updates From GILD, REGN, GSK, ANAB Down on Study Data, EWTX Gains Zacks
X1 week 3 No-Brainer Biotech Stocks to Buy With $200 Right Now Yahoo Finance
X1 week Eli Lilly’s Alzheimer’s treatment approved in China Investing.com
X1 week Eli Lilly Alzheimer’s drug donanemab approved in China Investing.com
X1 week Amgen (AMGN) Stock Moves -0.21%: What You Should Know Zacks
X1 week Eli Lilly (LLY) Stock Moves -0.05%: What You Should Know Zacks
X1 week NVS vs. LLY: Which Stock Should Value Investors Buy Now? Zacks
X1 week How to play a potential biotech breakout in 2025 with options CNBC
X1 week 4 Big Drug Stocks That May Continue to Outperform in 2025 Zacks
X1 week 15 Billion Reasons to Love Eli Lilly Stock Right Now Yahoo Finance
X1 week 3 Biotech Stocks With Promising Gene Therapies to Watch Out in 2025 Zacks
X1 week Eli Lilly: A Rare Buying Opportunity Seeking Alpha
X1 week ABBV’s Acquisition Spree Continues: Buy, Sell or Hold the Stock? Zacks
X1 week ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline Zacks
X1 week Battle Over Weight-Loss Drugs: Can Eli Lilly, Novo Nordisk Defend Their Turf? Investor's Business Daily
X1 week EMA Panel Endorses Lilly’s Omvoh for Expanded Use in Crohn’s Disease Zacks
X1 week Prediction: These Could Be the Best-Performing Pharma and Biotech Stocks Through 2030 Yahoo Finance
X2 weeks KRYS Stock Down on Initial Clinical Updates on KB407 & KB408 Zacks
XThe Stock Market News
TheStockMarketNews.com is a financial news aggregator for traders and investors that proposes to you the latest breaking news headlines on global financial markets, economy and business. Live trading analysis, opinions and forecasts on current stock market, currencies (Forex), cryptocurrency, commodities futures, ETFs, funds, bonds, rates and more. Disclaimer: by using any material of this website, you acknowledge and agree that TheStockMarketNews.com is not responsible for the content, actions or any legal issues arising from third-party websites; materials of this website are not financial advice or call to actions. Trading and investing in financial instruments involve high risks including the risk of investment loss.